comprehensive -WSS

comprehensive

author：fashion 2025-09-28 02:30:59 - browse：676

Dr. Laurie Glimcher, CEO of Dana Farber Cancer Institute, opens both arms while talking — coverage from STAT — Laurie Glimcher, CEO of Dana Farber Cancer Institute, is the architect of the biggest shakeup in Boston health care in decades. David L. Ryan/Globe Staff

Dr. Laurie Glimcher learned early on from her father, a prominent physician-researcher, that success in science was built on a basic principle: Big discoveries require big risks.

The younger Glimcher took that advice to heart. In the late 1990s at her Harvard immunology lab, Glimcher and her postdoctoral student began a series of experiments that colleagues deemed “crazy.” But after a year of trial and error, the lab had a eureka moment when it found that white blood cells could be reprogrammed, a seminal discovery that led to new ways to treat cancer.

“Most scientists do good work, but they don’t transform a scientific question,” said Glimcher. “I always felt the only way to do that is to think big and go after something that’s going to be really important.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： CommonSpirit Health keeps growing, even as it loses money

WSS

Unmasking the 'centricity' illusion in clinical trials

Louisiana bill approved classifying abortion pills as controlled substances

CDC advisers recommend seasonal use of Pfizer RSV shot

Hearing on Medicare drug price negotiation gets unusually heated

Beyond aggravation: Constipation is an American epidemic

Ozempic cut risk of death in diabetes patients with chronic kidney disease

leisure time

comprehensive

knowledge

United colonoscopy coverage change 'may cost lives,' doctors say

Ozempic cut risk of death in diabetes patients with chronic kidney disease

Novavax promises a turnaround & Lilly roils the obesity market

Drug for rare kidney disease narrowly misses mark in clinical trial

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Clinicians often fail to acknowledge the pain caused by long Covid

Drug repurposing or repositioning? The language matters

EpiPen alternative approval delay highlights citizen petition issue

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Thermo Fisher plant for manufacturing gene therapies to expand

leisure time

Guardant Health colon cancer test endorsed by FDA advisory panel

Lasker Awards 2023: Winners in biomedical research

Why some fertility treatments produce more boy babies

Achieving telehealth equity for people with hearing loss

EpiPen alternative approval delay highlights citizen petition issue

How AI helped researchers track recovery from depression

Wikipedia

entertainment

hotspot

leisure time